QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (130) Citing Articles via Google Scholar Google Scholar Articles by Wohlfarth, K. M. Articles by Macdonald, R. L. Search for Related Content PubMed PubMed Citation Articles by Wohlfarth, K. M. Articles by Macdonald, R. L.

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 1, 2002, 22(5):1541-1549

Enhanced Neurosteroid Potentiation of Ternary GABA_A Receptors Containing the  Subunit

Kai M. Wohlfarth¹, Matt T. Bianchi², and Robert L. Macdonald^{3, 4, 5}

Department of ¹  Neurology and ²  Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan 48104-1687, and Departments of ³  Neurology, ⁴  Molecular Physiology and Biophysics, and ⁵  Pharmacology, Vanderbilt University, Nashville, Tennessee 37212

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Attenuated behavioral sensitivity to neurosteroids has been reported for mice deficient in the GABA_A receptor  subunit. We therefore investigated potential subunit-specific neurosteroid pharmacology of the following GABA_A receptor isoforms in a transient expression system: 132L, 13, 632L, and 63. Potentiation of submaximal GABA_A receptor currents by the neurosteroid tetrahydrodeoxycorticosterone (THDOC) was greatest for the 13 isoform. Whole-cell GABA concentration-response curves performed with and without low concentrations (30 nM) of THDOC revealed enhanced peak GABA_A receptor currents for isoforms tested without affecting the GABA EC₅₀. 13 currents were enhanced the most (>150%), whereas the other isoform currents were enhanced 15-50%. At a higher concentration (1 µM), THDOC decreased peak 132L receptor current amplitude evoked by GABA (1 mM) concentration jumps and prolonged deactivation but had little effect on the rate or extent of apparent desensitization. Thus the polarity of THDOC modulation depended on GABA concentration for 132L GABA_A receptors. However, the same protocol applied to 13 receptors resulted in peak current enhancement by THDOC of >800% and prolonged deactivation. Interestingly, THDOC induced pronounced desensitization in the minimally desensitizing 13 receptors. Single channel recordings obtained from 13 receptors indicated that THDOC increased the channel opening duration, including the introduction of an additional longer duration open state. Our results suggest that the GABA_A receptor  subunit confers increased sensitivity to neurosteroid modulation and that the intrinsic gating and desensitization kinetics of 13 GABA_A receptors are altered by THDOC.

Key words: GABA_A receptor; subunit; neurosteroid; desensitization; single channel; gating

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Fast synaptic inhibition in the mammalian CNS is mediated mainly by activation of GABA_A receptor channels (Macdonald and Olsen, 1994; Whiting et al., 1995). GABA_A receptor function is modulated by various clinically important drugs that act on allosteric modulatory sites (Macdonald and Olsen, 1994; Sieghart, 1995). For example, neurosteroids, which represent a class of molecules that are synthesized in the nervous system, have been demonstrated to have anxiolytic, hypnotic, anesthetic, and anticonvulsant effects (Baulieu and Robel, 1990; Paul and Purdy, 1992; Macdonald and Olsen, 1994; Lambert et al., 1995) and may be involved in memory enhancement, behavioral actions, and neuroprotection (Frye, 1995; Green et al., 2000; Yoo et al., 1996).

Several studies have shown that neurosteroids bind to GABA_A receptors at sites different from GABA, benzodiazepines, and barbiturates (Gee et al., 1988; Turner et al., 1989) and can act as positive or negative modulators of receptor function (Majewska et al., 1986; Gee et al., 1988; Puia et al., 1990; Gee and Lan, 1991; Park-Chung et al., 1999). Neurosteroid enhancement of submaximal GABA_A receptor currents occurs through increases in both channel open frequency and open duration (Puia et al., 1990; Twyman and Macdonald, 1992). At high concentrations, neurosteroids can directly activate GABA_A receptor channels (Lambert et al., 1995).

The GABA_A receptor is a pentameric structure formed by the coassembly of subunit polypeptides from a large multigene family (McKernan and Whiting, 1996; Barnard et al., 1998) that are differentially expressed both temporally and spatially throughout the brain (Zheng et al., 1993, 1995). This heterogeneous expression confers specific physiological and pharmacological properties of GABA_A receptors (Sigel et al., 1990; Mathews et al., 1994). For example, it has been demonstrated that the presence of  and  subunits can affect neurosteroid modulation. The  subunit subtype was found to influence efficacy, whereas the  subunit subtype influenced both efficacy and EC₅₀ for neurosteroid interaction with GABA_A receptors (Gee and Lan, 1991; Lan et al., 1991; Sapp et al., 1992). Also, Zhu et al. (1996) reported that the presence of  subunits inhibited neurosteroid modulation but not direct activation, of GABA_A receptors. However, a recent study (Mihalek et al., 1999) demonstrated that mice lacking the GABA_A receptor  subunit had attenuated behavioral responses to systemic neurosteroid administration. This suggested an important role for the  subunit either in the neurosteroid modulation of GABA_A receptor currents or in the neural circuits relevant to the behavioral effects of neurosteroids. Approximately 30% of cerebellar GABA_A receptors are thought to contain the  subunit.  mRNA is also found in the hippocampus and thalamus (Benke et al., 1991; Laurie et al., 1992a,b; McKernan and Whiting, 1996).

We used whole-cell and single-channel patch-clamp recordings and applied GABA using an ultra fast application system to investigate neurosteroid allosteric modulation of GABA_A receptor currents in mammalian cells transiently transfected with recombinant GABA_A receptors containing 1 or 6 with 3 and 2L or  subunits.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Expression of recombinant GABA_A receptors. The cDNAs encoding rat 1, 6, 3, , and 2L GABA_A receptor subunit subtypes were individually subcloned into the plasmid expression vector pCMVNeo. All subunits have been sequenced and are identical to published sequences. Human embryonic kidney cells (HEK293T; a gift from P. Connely, COR Therapeutics, San Francisco, CA) were maintained in DMEM, supplemented with 10% fetal bovine serum, at 37°C in 5% CO₂/95% air. Cells were transfected with 4 µg of each subunit plasmid along with 1-2 µg of pHOOK (Invitrogen, Carlsbad, CA) for immunomagnetic bead separation (Greenfield et al., 1997), using a modified calcium phosphate coprecipitation technique as described previously (Angelotti et al., 1993). The next day, cells were replated, and recordings were made 18-30 hr later.

Electrophysiology and drug application. Patch-clamp recordings were performed on transfected fibroblasts bathed in an external solution consisting of (in mM): NaCl 142, KCl 8, MgCl₂ 6, CaCl₂ 1, HEPES 10, glucose 10, pH 7.4, 325 mOsm). Electrodes were formed from soda lime (whole cell), thin-walled borosilicate (whole cell), or thick-walled borosilicate (excised patch) glass (World Precision Instruments, Pittsburgh, PA) with a Flaming Brown electrode puller (Sutter Instrument Co., San Rafael, CA). Electrodes had resistances of 0.8-8.0 M when filled with an internal solution consisting of (in mM): KCl 153, MgCl₂ 1, MgATP 2, HEPES 10, EGTA 5, pH 7.3, 300 mOsm. Lower resistance electrodes were used for experiments in which cells were lifted from the recording dish (see Fig. 5). Higher resistance electrodes were used for single-channel recordings and were coated with Q-dope. The combination of internal and external solutions produced a chloride equilibrium potential near 0 mV. Unless stated otherwise, cells were voltage clamped at 10 to 75 mV using either an Axon 1D or a 200A amplifier (Axon Instruments, Foster City, CA). No voltage-dependent effects were observed in this range. Tetrahydrodeoxycorticosterone (THDOC) (Sigma, St. Louis, MO) was prepared as a 10 mM stock in dimethylsulfoxide (DMSO). THDOC was dissolved in external solution containing DMSO at a maximal final concentration of 0.1%. For most experiments, drugs were applied using a modified U-tube (Greenfield et al., 1997). For preapplication experiments, drugs were delivered (via gravity) to whole cells using a rapid perfusion system consisting of three-barrel square glass connected to a Warner Perfusion Fast-Step (Warner Instrument Corp., Hamden, CT). The glass was pulled to a final barrel size of ~250 µm. The solution exchange time was estimated routinely by stepping a dilute external solution across the open electrode tip to measure a liquid junction current. The 10-90% rise times for solution exchange were consistently 1-2 msec, although exchange was probably slower around cells. For single-channel experiments, drugs were applied either directly to the bath or via the multibarrel apparatus.

Analysis of currents. Whole-cell currents were low-pass filtered at 2-5 kHz, digitized at 10 kHz, and analyzed using the pCLAMP8 software suite (Axon Instruments). For concentration-response plots, peak currents evoked by GABA or THDOC at multiple concentrations were fitted to a sigmoidal function using a four-parameter logistic equation (sigmoidal concentration-response) with a variable slope. The equation used to fit the concentration-response relationship was I = I_(max)/1 + 10^(Log_EC50  Log_drug)*Hill slope, where I was the peak current at a given GABA concentration, and I_(max) was the maximal peak current. The desensitization and deactivation time courses of GABA_A receptor currents elicited with the concentration jump technique were fit using the Levenberg-Marquardt least squares method with one or two or three component exponential functions of the form  a_nn, where n is the best number of exponential components, a is the relative amplitude of the component, and  is the time constant. Additional components were accepted only if they significantly improved the fit, as determined by an F test on the sum of squared residuals. For comparison of deactivation time courses, a weighted summation of the fast and slow decay components (a_f * _f + a_s * _s) was used. Single-channel data were digitized at 20 kHz, filtered at 2 kHz via the internal Axon 200A amplifier filter, and stored on VHS videotape for analysis off-line. Stretches of single-channel activity were analyzed using the 50% threshold detection method of Fetchan 6.0 (pClamp 8.0). Overlapped openings and bursts were not included in the analysis. Although overlapping openings, indicating multiple channels, were observed in most patches, they would not affect the open duration histograms. Open duration histograms were generated and fitted using Interval5 software (Dr. Barry S. Pallotta, University of North Carolina, Chapel Hill, NC). The number of exponential functions required to describe the data was determined by a log-likelihood method (additional components were accepted if they significantly improved the fit). Events with durations <150 µsec (1.5 times the system dead time) were shown in the plots but were not considered by the fitting routine. Additional data reduction and filtering were implemented for figure display purposes only. Numerical data were expressed as mean ± SEM. Statistical significance, using Student's t test (two-tailed, paired, or unpaired as appropriate) was taken as p < 0.05.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Direct activation by THDOC depended on subunit composition

All constructs produced THDOC-sensitive currents in HEK293T cells. Cells were voltage clamped at 65 mV, and whole-cell currents were recorded in response to increasing concentrations of THDOC (Fig. 1A,C). The GABA_A receptor isoforms exhibited different THDOC sensitivities (EC₅₀ values) (Fig. 1C). Although there is little mechanistic information in this analysis, it is necessary to describe direct activation so that appropriate concentrations can be chosen for subsequent modulation experiments (see below). Additionally, we observed a subunit and subtype dependence of the direct effects of THDOC. 6 subtype-containing receptors had lower EC₅₀ values for THDOC activation than 1 subtype-containing receptors (p < 0.05), similar to observations for GABA concentration-response curves (Fisher et al., 1997) (Fig. 1C, Table 1). The 132L isoform was ~2.5-fold less sensitive to THDOC than the 632L isoform. The 13 isoform was at least sixfold less sensitive to THDOC than the 63 isoform. Regarding the 13 receptor complex, a complete concentration-response curve could not be obtained because of high final DMSO concentration (>0.3%) with higher THDOC concentrations (>30 µM). The direct activation was first observed at 30-100 nM THDOC for all receptor isoforms. At higher concentrations of THDOC (>10 µM), a "rebound" current was observed on washout in all constructs. The rebound was more clearly evident under conditions of faster perfusion (Fig. 1B), which may explain why this effect was not reported previously. Maximum currents were significantly different between 2L and  subunit-containing receptors (p < 0.05) (Table 1). THDOC elicited larger currents from GABA_A receptors containing the 2L subunit than from receptors containing the  subunit (Fig. 1C, Table 1). 13 and 63 isoforms showed current amplitudes intermediate between and isoforms (Fig. 1C). For each isoform, maximum currents were in the same range of peak amplitudes when evoked by THDOC or GABA (data not shown).

View larger version (25K): [in this window] [in a new window]   Figure 1.   Direct activation of GABAA receptors by THDOC. A, Representative currents evoked by increasing THDOC concentrations for 132L (), 13 (), 632L (), 63 (), 13 (), and 63 () GABAA receptor isoforms. The hatched bars indicate application of various THDOC concentrations. Note the small inflections in the currents after application of 30 µM THDOC. B, Concentration jump using 10 µM alphaxalone shows a rebound current more clearly because of faster solution exchange (see Materials and Methods). C, Concentration-response relations for direct activation by THDOC. Mean ± SEM current amplitudes are shown. The left and right panels show 1- and 6-containing isoforms, respectively. Smaller currents were observed for  subunit-containing isoforms. Symbols are as in A. See Table 1 for fitted parameters.

View this table: [in this window] [in a new window]   Table 1.   Pharmacological properties of studied GABAA receptors

THDOC produced increased modulation of 13 receptor currents

To evaluate the effect of subunit composition on THDOC modulation of GABA_A receptor currents, increasing concentrations of THDOC were coapplied with an EC₃₀ GABA concentration determined for each isoform. Low THDOC concentrations (<300 nM) were considered "modulatory" concentrations, because little or no direct activation was observed in this range in whole-cell recordings. Higher concentrations of THDOC resulted in more substantial direct activation of GABA_A receptor currents. Neurosteroid modulation was observed for all isoforms tested (Fig. 2). For 13 receptors, the extent of the modulatory effect was more pronounced than for the other isoforms. For 13 and 132L receptors, a significant difference in THDOC-induced potentiation was detected for concentrations of 100 nM, 300 nM, and 1 µM (p < 0.05). At concentrations below 100 nM, the modulatory effect of THDOC was not significant different among all isoforms tested. Replacement of  with 2L subunits reduced the apparent GABA_A receptor sensitivity to THDOC potentiation. The 6 subtype-containing GABA_A receptors were enhanced similarly by THDOC, whether the  or 2L subunit was present.

View larger version (21K): [in this window] [in a new window]   Figure 2.   Modulation of submaximal GABA-evoked currents by THDOC coapplication. A, Current traces showing THDOC enhancement of EC30 GABA concentrations for 132L () and 13 () GABAA receptors. Hatched bars indicate THDOC application; filled bars indicate GABA application. B, Summary plot of THDOC enhancement of currents evoked by EC30 GABA concentration for each isoform. Data from lower THDOC concentrations are expanded in the inset for clarity. Significant potentiation was observed for THDOC concentrations of 100 nM and higher (p < 0.05).

THDOC enhanced GABA_A receptor currents without changing the GABA EC₅₀

Although concentration-response curves are empirical descriptions and do not specify any particular mechanism, the effect of modulators on the GABA concentration-response relation can provide insight into modulator mechanism(s) of action. Thus, complete GABA concentration-response curves with and without 30 nM THDOC were obtained for each isoform (Fig. 3). A THDOC concentration of 30 nM was chosen as a modulatory concentration because it was less than EC₅ for THDOC direct activation for each isoform (Fig. 1), thus minimizing the effect of direct activation. Furthermore, in each cell, 30 nM THDOC was applied alone to verify the minimal activation of current compared with GABA-evoked currents and to confirm that such currents, when present, were not significantly affecting the analysis. For all GABA_A receptor isoforms tested, THDOC clearly enhanced the GABA-activated currents. Although the GABA EC₅₀ values remained unchanged, the maximum currents were significantly enhanced for each isoform (p < 0.05) (Table 1). The extent of potentiation by THDOC was significantly greater for the 13 isoform (Fig. 3C) than for the 132L isoform (Fig. 3A) and the 13 isoform (Fig. 3E) (p < 0.05). No significant difference in THDOC-induced potentiation was detected among 632L, 63, and 63 receptors (Fig. 3B,D,F). Focusing on  subunit subtype dependence, the extent of potentiation by THDOC was significantly higher for 13 isoforms than for 63 isoforms (p < 0.05) and higher for 63 than for 13 isoforms (p < 0.05), whereas no significant difference was found between GABA_A receptors containing 132L and 632L subunits.

View larger version (29K): [in this window] [in a new window]   Figure 3.   THDOC enhanced the maximal GABAA receptor currents without changing the GABA EC50. A-D, GABA concentration-response curves were obtained in the absence () and presence () of 30 nM THDOC for 132L (A), 13 (B), 632L (C), 63 (D), 13 (E), and 63 (F) isoforms. Representative maximal GABA currents without () and with () THDOC coapplication are shown in the inset of A-D. For the GABA plus THDOC curves, the currents were normalized to the amplitude of a 100 µM GABA test pulse obtained from the same cell. Fitted parameters are given in Table 1.

Neurosteroid modulation changed polarity at high GABA concentration

To investigate further the differences in neurosteroid modulation of 132L and 13 isoforms at high GABA concentration likely to occur at synapses, we coapplied increasing concentrations of THDOC with 1 mM GABA (Fig. 4A). We chose these two GABA_A receptors because of the significant difference in their THDOC-induced modulation described earlier. Consistent with previous data from cerebellar granule neurons (Zhu and Vicini, 1997), at a saturating concentration of GABA, the polarity of THDOC modulation of 132L receptors reversed (Fig. 4B): peak currents were inhibited by THDOC in a concentration-dependent manner. In contrast, 13 receptor currents were increasingly potentiated by THDOC concentrations (up to 30 µM) (Fig. 4B). Although direct activation of GABA_A receptor currents occurred at high THDOC concentrations, the strong potentiation observed for 13 receptors could not be accounted for simply by increased direct activation (Fig. 5).

View larger version (16K): [in this window] [in a new window]   Figure 4.   Modulation of maximal GABA-evoked currents by THDOC coapplication. A, Increasing concentrations of THDOC were coapplied with 1 mM GABA to 132L () and 13 () GABAA receptors. Representative traces are shown for each isoform. Hatched bars indicate THDOC application; filled bars indicate GABA application. B, Summary of THDOC modulation, showing increasing enhancement for 13 receptors and inhibition for 132L receptors. The dashed line indicates 100% of control (1 mM GABA alone) current amplitude. Symbols indicate the mean ± SEM responses of four cells for each isoform.

View larger version (22K): [in this window] [in a new window]   Figure 5.   Kinetics and polarity of THDOC modulation depend on subunit composition and GABA concentration. THDOC (1 µM) was preapplied with 1 µM GABA (A, B) and 1 mM GABA (C, D) using the concentration jump technique. Hatched bars indicate THDOC application; filled bars indicate GABA application. For the rapidly desensitizing 132L receptors, cells were lifted from the recording dish to increase resolution of the peak currents. Direct activation was observed during the preapplication for both isoforms, with greater relative currents evoked from 132L. Greater enhancement of 1 µM GABA currents was observed for 13 receptors, although both isoforms showed slightly increased desensitization and prolonged deactivation (A, B). With 1 mM GABA, 13 receptors were enhanced substantially and pronounced desensitization was observed (C), whereas 132L receptors were slightly inhibited (D). The control trace in D was normalized and overlaid in gray to show the minimal effect on apparent desensitization. The dashed line emphasizes the decreased peak current in the presence of THDOC.

THDOC altered the macroscopic desensitization of 13 GABA_A receptor currents

Having established a clear difference between modulation of 132L and 13 currents by THDOC, we used the concentration jump technique to determine the effects on macroscopic kinetics using preapplication of THDOC (Figs. 5, 6). After obtaining a control response to GABA, cells were jumped from control solution to THDOC (1 µM) alone for preincubation of at least 1.5 sec, then to THDOC (1 µM) plus GABA (1 mM) for 4 sec, and then allowed to deactivate in the presence of THDOC (1 µM) alone. This allowed us to separate the effects of direct activation from modulation of the currents (because the THDOC was preapplied), and the rapid solution changes allowed better resolution of peak currents, desensitization, and deactivation. Also, the preapplication protocol ensured that the receptors were equilibrated with THDOC at the time of GABA application. THDOC (1 µM) reversibly potentiated both 13 (Fig. 5A) and 132L (Fig. 5B) GABA_A receptor currents elicited by low (~EC₃₀) concentrations of GABA. The mean enhancement was fourfold larger for 13 GABA_A receptors (~1600%; n = 6) than for 132L receptors (~400%; n = 6) (p < 0.05) (Fig. 6A, left pair of bars). Although the potentiated currents desensitized to a greater extent (measured as the percentage of current "lost" relative to peak current) than control currents for both isoforms, this effect was more pronounced for 132L receptors. The left half of Figure 6B shows the subunit-dependent differences in desensitization extent in the presence of low concentration GABA with or without THDOC (compare open and shaded bars for each isoform). After washout of 1 µM GABA, the deactivation rate of THDOC-modulated currents was prolonged similarly for both isoforms (~250%) (Fig. 5A,B). The left pair of bars in Figure 6C shows THDOC-induced changes in the time constant of deactivation after washout of low concentration GABA.

View larger version (30K): [in this window] [in a new window]   Figure 6.   Summary of THDOC effects on peak currents, desensitization, and deactivation. A, Effect of THDOC (1 µM) on currents evoked by 1 µM and 1 mM GABA for 13 (gray bars) and 132L (black bars) GABAA receptors. Values are expressed as a percentage of current evoked by GABA alone for each cell. Note the logarithmic axis. The dashed line indicates 100% of control current amplitude. B, Percentage increase in the weighted time constant of deactivation for the same conditions as in A. The dashed line indicates 100% of control deactivation. C, Extent of desensitization observed with 1 mM GABA alone (white bars) or 1 mM GABA + 1 µM THDOC (gray bars) for 13 and 132L GABAA receptors. Data are expressed as the percentage of peak current lost during a 4 sec application of GABA or GABA + THDOC. D, The rates of desensitization during a 4 sec pulse of 1 mM GABA for 13 and 132L GABAA receptors in the absence (white bars) and presence of preapplied 1 µM THDOC. 132L GABAA receptor responses were fitted best by three exponentials with similar time constants and relative areas (data not shown) whether or not THDOC was present. Although the small amount of desensitization observed for 13 in the presence of GABA alone was not well fitted (*, the time constant was longer than the pulse duration), the pronounced desensitization observed in the presence of THDOC had a weighted time constant ~2 sec. The data are from four to eight cells per condition.

The polarity of THDOC modulation of currents evoked by coapplication of a saturating (1 mM) concentration of GABA depended on subunit composition (Fig. 4). Similar results were observed during concentration jump experiments in which THDOC was preapplied. After a control response to GABA alone (1 mM) was obtained, cells were jumped into THDOC alone (1 µM) for a 1.5 sec preincubation followed by a 4 sec pulse of GABA + THDOC and then allowed to deactivate in the presence of THDOC. 13 GABA_A receptors were enhanced by ~800% (n = 8) (Fig. 5C), whereas 132L GABA_A receptors were inhibited ~20% (n = 4) (Fig. 5D). The right half of Figure 6A summarizes this difference in THDOC modulation of peak current using saturating GABA concentration. The concentration jump experiments allowed resolution of subunit-dependent differences in the macroscopic kinetics of THDOC modulation as well. Specifically, THDOC (1 µM) substantially increased the rate and extent of desensitization of 13 currents (Figs. 5C, 6B). 13 receptors normally exhibit minimal desensitization, even in the presence of saturating (1 mM) GABA concentrations (Fig. 6B) (Saxena and Macdonald, 1994; Haas and Macdonald, 1999). In contrast, peak currents were inhibited, and the extent of macroscopic desensitization was unaltered by THDOC for 132L receptor currents (Fig. 5D). Figure 6B (right half) summarizes the changes in extent of desensitization when 1 mM GABA was applied with or without THDOC (1 µM). Furthermore, the time course of desensitization of 132L receptor currents evoked by 1 mM GABA was fitted best with the sum of three exponential functions with similar rate constants in the presence or absence of THDOC (Fib. 6D, left portion, compare open and shaded bars). The rate of desensitization could not be measured accurately for 13 receptors during 4 sec pulses (because the time constant was much longer than the application duration). However, in the presence of THDOC, the weighted desensitization time constant decreased to ~2 sec (Fig. 6D). Although current deactivation after washout of 1 mM GABA was prolonged by THDOC (1 µM) for both isoforms, the relative increase was smaller for 132L GABA_A receptors (p < 0.05) (Fig. 6C, right pair of bars).

THDOC introduced a third, longer open state for 13 GABA_A receptors

Single-channel recordings were obtained from 13 receptors to investigate the basis for the large change in efficacy produced by THDOC. Consistent with our previous reports (Fisher and Macdonald, 1997; Haas and Macdonald, 1999), 13 GABA_A receptor single-channel openings evoked during steady-state application of 1 mM GABA were brief (Fig. 7A1), with a mean open duration of 0.445 ± 0.026 msec (Table 2). The distribution of open durations was best described by the sum of two exponential functions with time constants of ~300 µsec and ~1 msec (Fig. 7A2). Coapplication of 1 µM THDOC increased the mean channel opening duration. The distribution of open durations required a third exponential function to account for the longer openings, with a time constant of 5.94 ± 0.98 msec and relative area of 9.8 ± 2.9%. Although the shortest exponential function had a similar time constant, the second time constant and its relative area were increased significantly compared with the openings evoked by GABA alone (p < 0.05) (Table 2). Because THDOC (1 µM) can directly activate GABA_A receptor currents, we also measured single-channel currents from 13 GABA_A receptors in the presence of THDOC (1 µM) alone. The mean open duration was not different from that observed with GABA alone, and the first two open durations were also unchanged in terms of time constant and relative area (Table 2). However, a third open state with small relative area (4.0 ± 1.6%) was required to fit the distribution. The longer open state in the presence of THDOC alone accounted for 12.4% of the charge passed, whereas the longer open state in the presence of both drugs accounted for 39.0% of the charge passed. Although neurosteroids have been reported to increase the frequency of channel openings, we did not consider changes in open frequency because of the confounding appearance of desensitization in the presence of THDOC macroscopically (Fig. 5). At the single-channel level, quiescent periods rarely observed with GABA alone would decrease overall opening frequency in the presence of GABA and THDOC for 13 GABA_A receptor channels.

View larger version (29K): [in this window] [in a new window]   Figure 7.   THDOC enhanced single-channel open duration in 13 GABAA receptor single channels. Representative 13 GABAA receptor single-channel currents evoked by 1 mM GABA alone (A1), 1 mM GABA + 1 M THDOC (B1), and 1 M THDOC alone (C1). A portion of the top trace in each panel is expanded in the trace directly beneath it (indicated by the open bar). The traces in A1 and B1 are from the same patch. The larger scale factor applies to the top traces. A2, B2, and C2 are the open duration histograms for all patches obtained for each condition (n = 3, 5, and 3 respectively). Superimposed lines are the fitted exponential functions describing the distributions.

View this table: [in this window] [in a new window]   Table 2.   Single-channel opening properties for 13 GABAA receptors

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

GABA_A receptors are targets for CNS actions of neurosteroids. Our results demonstrated a novel subunit dependence of neurosteroid action. Specifically, receptors containing the  subunit were preferentially enhanced by the neurosteroid THDOC. THDOC affected both the single-channel gating kinetics and the macroscopic desensitization of 13 GABA_A receptor channels. These findings may be the basis for the attenuated neurosteroid sensitivity in mice lacking the  subunit (Mihalek et al., 1999). Additionally, our results suggest the importance of GABA concentration for THDOC modulation of receptors containing the 2 subunit.

It is believed that neurosteroids, like barbiturates, exert their action on GABA_A receptors via two distinct binding sites (Majewska et al., 1986; Gee et al., 1988; Turner et al., 1989; Lambert et al., 1995, 1996; Zorumski et al., 1998; Park-Chung et al., 1999). Low (nanomolar) concentrations of neurosteroids allosterically enhance GABA-mediated currents, whereas higher (micromolar) concentrations directly activate GABA_A receptors. We observed a rebound current on washout of THDOC for concentrations 10 µM in all tested GABA_A receptor isoforms. This phenomenon may indicate a third binding site, presumably within the channel pore, that produces a low-affinity open-channel block similar to that observed for barbiturates.

Although no clear subunit specificity has been demonstrated for neurosteroid modulation of GABA_A receptor currents as there has been for benzodiazepine modulation of GABA_A receptor currents (Lambert et al., 1995), the  and  subunits in GABA_A receptors have some influence on the EC₅₀ and efficacy of modulation by neurosteroids such as THDOC that act as positive modulators (Puia et al., 1993). Puia et al. (1990) and Zhu et al. (1996) reported no subunit-dependent differences in the sensitivity to THDOC activation or amplitude of THDOC-evoked currents among different GABA_A receptor isoforms. However, our results indicate that the 1 and 6 subtypes conferred different EC₅₀ values for THDOC, similar to the difference reported for GABA (Fisher et al., 1997). THDOC and GABA were equally effective as agonists for all studied GABA_A receptors, as indicated by peak currents obtained in whole-cell recordings. However, the maximum current amplitudes produced by THDOC and GABA were larger for  than for  subunit-containing receptors, which might be related to differences in expression efficiency or intrinsic gating efficacy. This difference has been reported for currents evoked by GABA as well (Fisher and Macdonald, 1997; Haas and Macdonald, 1999). However, the basis for this difference remains unclear.

Zhu et al. (1996) reported that incorporation of the  subunit inhibited the modulatory (but not the direct) effect of THDOC on GABA_A receptor currents. In contrast, we found a significant neurosteroid potentiation in all tested receptors, and 13 receptors were potentiated more than 132L and 13 receptors. Replacement of GABA_A receptor 1 with 6 subtypes in receptors decreased the extent of THDOC potentiation, although THDOC enhanced both 132L and 632L GABA_A receptor currents to similar extents. The latter finding contrasts with previous reports showing a decrease in steroid sensitivity with 6 compared with 1 in combinations (Puia et al., 1993; Zhu et al., 1996). Neurosteroid modulation of 13 receptor currents was greater than that of 63 and 132L GABA_A receptor currents. However, dentate granule cells become less sensitive to THDOC with developmental progression (Cooper et al., 1999), despite an increase in  subunit expression in this brain region (Laurie et al., 1992a). This may be related to variable steroid modulation when  subunits coassemble with  subtypes other than 1, or when  and  subunits are present in the same receptor. Additionally, it is possible that a neuronal environment alters the sensitivity of GABA_A receptors. In fact, by combining electrophysiological recordings and single-cell PCR techniques, Zhu and Vicini (1996) observed an inverse relation between the presence of  subunit mRNA and neurosteroid potentiation in cultured cerebellar granule cells. Also, there is evidence for a phosphorylation dependence of allopregnanalone modulation of GABAergic IPSCs in the hypothalamus (Fancsik et al., 2000). Such post-translational receptor modifications may contribute to potential differences between neuronal preparations and recombinant systems, among other cellular processes. Nevertheless, our results indicated that  subunit-containing GABA_A receptors are clearly enhanced by neurosteroids, particularly in combination with the 1 subunit subtype, suggesting a critical role for the  subunit in the assembly of neurosteroid-sensitive GABA_A receptors. This observation is strengthened by the small degree of potentiation observed in 13 GABA_A receptors. The enhanced THDOC sensitivity of isoforms was in agreement with a recent report by Mihalek et al. (1999), who found that the absence of the  subunit resulted in a significant decrease in the sensitivity to neurosteroids. However, the precise mechanism by which the  subunit knock-out attenuated neurosteroid effects awaits further study. It should be noted that GABA_A receptors containing both 2 and  subunits may be present in vivo. Whether the presence of a  subunit would have a "dominant" effect on neurosteroid modulation remains unknown. Our data also support a recent study showing preferential steroid enhancement of 43 over 432 GABA_A receptors (Adkins et al., 2001).

We have shown previously that incorporation of the  subunit abolishes fast desensitization and reduces the overall rate and extent of desensitization (Saxena and Macdonald, 1994; Haas and Macdonald, 1999; Bianchi et al., 2001). Even at saturating (1 mM) GABA concentrations, minimal desensitization and relatively fast deactivation are observed. However, in this study we found pronounced desensitization in 13 GABA_A receptors in the presence of 1 µM THDOC. This was probably not caused by open channel block because single-channel open durations were longer, not shorter as would be expected with such a mechanism. The apparent desensitization was accompanied by substantially prolonged deactivation. Although this finding is consistent with the suggested role of desensitized states in the duration of current deactivation (Jones and Westbrook, 1995, 1996), an increase in open frequency and duration could also prolong deactivation. In fact, single-channel recordings revealed that THDOC enhanced current through 13 GABA_A receptors, at least through an increase in mean open duration. Steroids were reported previously to increase open duration (Mistry and Cottrell, 1990) and increase frequency as well as duration (Twyman and Macdonald, 1992) in native GABA_A receptor single channels obtained from mouse spinal neurons, although it is unlikely that these channels contained the  subunit. We did not analyze open frequency because of the introduction of desensitized states in 13 GABA_A receptors. Periods of desensitization, however, would not confound the analysis of open durations. Although saturating GABA concentrations evoked single-channel openings best described by two exponential functions, a third longer duration open state was observed in the presence of THDOC. We propose that THDOC alters the intrinsic gating behavior of 13 GABA_A receptors in at least two ways: (1) by allowing entry into otherwise unavailable desensitized states and (2) by increasing the gating efficacy via changes in opening duration. This change was attributable to an increase in the time constant of the second open state (1.8 compared with 1.0 msec; p < 0.05), a change in the relative proportion of the first and second open states, and the introduction of an additional longer open state (Table 2). Note that the modulation of single-channel gating was measured at steady state, so no direct comparisons (in terms of the magnitude of THDOC modulation) can be made with the transient applications performed on whole cells. Although the binding of GABA alone appears insufficient to allow entry into the longer open state, the concomitant binding of THDOC favors transitions to the longer state. Interestingly, THDOC alone (1 µM) activated single-channel events that were well described by three exponential functions, suggesting that neurosteroid binding alone may be sufficient to favor longer openings, although these longer openings were shorter and less frequent than the longer openings observed in the presence of both drugs. Thus it is unlikely that receptors bound only by THDOC contributed to the distinct gating behavior observed in the presence of both drugs. Additionally, the concentration of GABA (1 mM) was more than two orders of magnitude above the functional EC₅₀ value for the 13 combination, resulting in near-saturating occupancy of the GABA binding sites at steady state. It remains unclear whether this effect is unique to the 13 isoform. However, given the weakly inhibited amplitude and similar desensitization time course in the presence of THDOC, it is unlikely that such dramatic effects on single-channel gating would be observed for 132L GABA_A receptor single channels.

The action of THDOC on channel gating kinetics may be analogous to the effects of barbiturates, which have been shown to prolong native (likely ) GABA_A receptor single-channel mean open time by shifting the relative distribution of existing open durations, and similar effects were observed for neurosteroids (Twyman et al., 1989; Twyman and Macdonald, 1992). However, because the longer open state is not significant in the presence of GABA alone, we cannot explicitly demonstrate that this state can be accessed "naturally" by receptors bound by GABA alone. It is unknown whether barbiturates or other modulators can alter the gating behavior of GABA_A receptors in a manner similar to THDOC.

For 132L GABA_A receptors, modulation of maximal currents by 1 µM THDOC was similar to that reported for cerebellar granule neurons (Zhu and Vicini, 1997) in that peak currents were depressed and deactivation was prolonged, despite no change in the time course of desensitization. This effect contrasts with neurosteroid potentiation of currents activated by low GABA concentration in cerebellar granule neurons (Zhu and Vicini, 1997) and 132L GABA_A receptors (this study). Although nucleated patches obtained from cerebellar granule neurons in that study were likely to contain extrasynaptic receptors [which Nusser et al. (1998) reported to contain the  subunit], our data are consistent with 2 subunit- but not  subunit-containing isoforms being predominant in that preparation.

In the cerebellum,  subunit-containing receptors are thought to be extrasynaptic, whereas synaptic receptors are thought to preferentially contain the 2 subunit (Nusser et al., 1998). However, Mihalek et al. (1999) suggested  subunit involvement in normal synaptic transmission in the dentate gyrus. Although the synaptic concentration of GABA remains controversial, our results and those of others (Harrison et al., 1987; Zhu and Vicini, 1997) suggest that neurosteroids may modulate IPSCs in at least two ways: (1) by changing the peak current (either positively or negatively, depending on the concentration of both GABA and the neurosteroid) and (2) by prolonging the duration of the IPSC (by slowing deactivation) independent of the GABA concentration. For extrasynaptic isoforms, neurosteroids may increase basal levels of inhibition by increasing the response to ambient GABA levels. It is also possible that modulation of neuronal circuits necessary for neurosteroid effects depend (either directly or indirectly) on GABA_A receptors containing the  subunit.

In summary, our results showed that the subunit composition of GABA_A receptors is an important determinant of the neurosteroid modulation of GABA_A receptor activity. Although the precise contribution of GABA_A receptor combinations toward the in vivo effects of neurosteroids remains to be elucidated, the enhanced potentiation of 13 GABA_A receptors may indicate a critical role for this isoform.

	FOOTNOTES

Received Oct. 26, 2001; revised Nov. 29, 2001; accepted Dec. 6, 2001.

This work was supported by National Institutes of Health Grant R01-NS33300 (R.L.M.), the Deutsche Forschungsgemeinschaft WO 770/1-1 (K.M.W.), and a National Institute on Drug Abuse training fellowship T32-DA07281-03 (M.T.B.).

Correspondence should be addressed to Dr. Robert L. Macdonald, Department of Neurology, Vanderbilt University, 2100 Pierce Avenue, Nashville, TN 37212. E-mail: Robert.Macdonald{at}mcmail.vanderbilt.edu.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

• Adkins CE, Pillai GV, Kerby J, Bonnert TP, Haldon C, McKernan RM, Gonzalez JE, Oades K, Whiting PJ, Simpson PB (2001) 43 GABA_A receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J Biol Chem 276:38934-38939[Abstract/Free Full Text].
• Angelotti TP, Uhler MD, Macdonald RL (1993) Assembly of GABA_A receptor subunits: analysis of transient single-cell expression utilizing a fluorescent substrate/marker gene technique. J Neurosci 13:1418-1428[Abstract].
• Barnard EA, Skolnick P, Olson RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) International Union of Pharmacology. XV. Subtypes of -aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291-313[Abstract/Free Full Text].
• Baulieu E-E, Robel P (1990) Neurosteroids: a new brain function? J Steroid Biochem Mol Biol 37:395-403[Web of Science][Medline].
• Benke D, Meterns S, Trzeciak A, Gillesen D, Mohler H (1991) Identification and immunohistochemical mapping of GABA_A receptor subtypes containing the  subunit in rat brain. FEBS Lett 283:145-149[Web of Science][Medline].
• Bianchi MT, Haas KF, Macdonald RL (2001) Structural determinants of fast desensitization and desensitization-deactivation coupling in GABA_A receptors. J Neurosci 21:1127-1136[Abstract/Free Full Text].
• Cooper EJ, Johnston GAR, Edwards FA (1999) Effects of naturally occurring neurosteroid on GABA_A IPSCs during development in rat hippocampal or cerebellar slices. J Physiol (Lond) 521.2:437-449[Abstract/Free Full Text].
• Fancsik A, Linn DM, Tasker JG (2000) Neurosteroid modulation of GABA IPSCs is phosphorylation dependent. J Neurosci 20:3067-3075[Abstract/Free Full Text].
• Fisher JL, Macdonald RL (1997) Single channel properties of GABA_A receptors containing 2 or  subtypes expressed with 1 and 3 subtypes in L929 cells. J Physiol (Lond) 505:283-297[Abstract/Free Full Text].
• Fisher JL, Zhang J, Macdonald RL (1997) The role of 1 and 6 subtype amino-terminal domains in allosteric regulation of -aminobutyric acid_a receptor. Mol Pharmacol 52:714-724[Abstract/Free Full Text].
• Frye CA (1995) The neurosteroid 3 alpha, 5 alpha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 696:113-120[Web of Science][Medline].
• Gee KW, Lan NC (1991) -Aminobutyric acid_A receptor complexes in rat cortex and spinal cord show differential responses to steroid modulation. Mol Pharmacol 40:995-999[Abstract].
• Gee KW, Bolger MB, Brinton RE, Coirini H, McEwen BS (1988) Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246:803-812[Abstract/Free Full Text].
• Green AR, Hainsworth AH, Jackson DM (2000) GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology 39:1483-1494[Web of Science][Medline].
• Greenfield Jr LJ, Sun F, Neelands TR, Burgard EC, Donnelly IL, Macdonald RL (1997) Expression of functional GABA_A receptors in transfected L929 cells isolated by immunomagnetic bead separation. Neuropharmacology 36:63-73[Web of Science][Medline].
• Haas KF, Macdonald RL (1999) GABA_A receptor subunit 2 and  subtypes confer unique kinetic properties on recombinant GABA_A receptor currents in mouse fibroblasts. J Physiol (Lond) 514:27-45[Abstract/Free Full Text].
• Harrison NL, Vicini S, Barker JL (1987) A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. J Neurosci 7:604-609[Abstract].
• Jones MV, Westbrook GL (1995) Desensitized states prolong GABA_A channel responses to brief agonist pulses. Neuron 15:181-191[Web of Science][Medline].
• Jones MV, Westbrook GL (1996) The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci 19:96-101[Web of Science][Medline].
• Lambert JJ, Belelli D, Hill-Venning C, Peters JA (1995) Neurosteroids and GABA_A receptor function. Trends Pharmacol Sci 16:295-303[Medline].
• Lambert JJ, Belelli D, Hill-Venning C, Peters JA (1996) Neurosteroid modulation of native and recombinant GABA_A receptors. Cell Mol Neurobiol 16:155-174[Web of Science][Medline].
• Lan NC, Gee KW, Bolger MB, Chen JS (1991) Differential responses of expressed recombinant human -aminobutyric acid_A receptors to neurosteroids. J Neurochem 57:1818-1821[Web of Science][Medline].
• Laurie DJ, Seeburg PH, Wisden W (1992a) The distribution of thirteen GABA-A receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci 12:1063-1076[Abstract].
• Laurie DJ, Seeburg PH, Wisden W (1992b) The distribution of thirteen GABA-A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12:4151-4172[Abstract].
• Macdonald RL, Olsen RW (1994) GABA_A receptor channels. Annu Rev Neurosci 17:569-602[Web of Science][Medline].
• Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004-1007[Abstract/Free Full Text].
• Mathews GC, Bolos-Sy AM, Holland KD, Isenberg KE, Covey DF, Ferrendelli JA, Rothman SM (1994) Developmental alteration in GABA_A receptor structure and physiological properties in cultured cerebellar granule neurons. Neuron 13:149-158[Web of Science][Medline].
• McKernan RM, Whiting PJ (1996) Which GABA_A receptor subtypes really occur in the brain? Trends Neurosci 19:139-143[Web of Science][Medline].
• Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi Z-P, Lagenaur C, Tretter V, Sieghart W, Anagnostaras G, Sage JR, Fanselow MS, Guidotti A, Spigelman I, Li Z, DeLorey TM, Olsen RW, Homanics GE (1999) Attenuated sensitivity to neuroactive steroids in -aminobutyrate type A receptor delta subunit knock-out mice. Proc Natl Acad Sci USA 96:12905-12910[Abstract/Free Full Text].
• Mistry DK, Cottrell GA (1990) Actions of steroids and bemegride on the GABAA receptor of mouse spinal neurones in culture. Exp Physiology 75:199-209[Abstract].
• Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABA_A receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18:1693-1703[Abstract/Free Full Text].
• Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH (1999) Sulfated and unsulfated steroids modulate -aminobutyric acid_A receptor function through distinct sites. Brain Res 830:72-87[Web of Science][Medline].
• Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311-2322[Abstract].
• Puia G, Santi MR, Vicini S, Pritchett DB, Purdy RH, Paul SM, Seeburg PH, Costa E (1990) Neurosteroids act on recombinant human GABA_A receptor. Neuron 4:759-765[Web of Science][Medline].
• Puia G, Ducic I, Vicini S, Costa E (1993) Does neurosteroid modulatory efficacy depend on GABA_A receptor subunit composition? Receptors Channels 1:135-142[Web of Science][Medline].
• Sapp DW, Witte U, Turner DM, Longoni B, Kokka N, Olsen RW (1992) Regional variation in steroid anesthetic modulation of [³⁵S]TBPS binding to -aminobutyric acid_A receptors in rat brain. J Pharmacol Exp Ther 262:801-806[Abstract/Free Full Text].
• Saxena NC, Macdonald RL (1994) Assembly of GABA_A receptor subunit: role of the  subunit. J Neurosci 14:7077-7086[Abstract].
• Sieghart W (1995) Structure and pharmacology of -aminobutyric acid_A receptor subtypes. Pharmacol Rev 47:181-234[Web of Science][Medline].
• Sigel E, Baur R, Trube G, Möhler H, Malherbe P (1990) The effect of subunit composition of rat brain GABA_A receptors on channel function. Neuron 5:703-711[Web of Science][Medline].
• Turner DM, Ransom RW, Yang JS-J, Olsen EW (1989) Steroid anesthetics and naturally occurring analogs modulate the -aminobutyric acid receptor complex at a site distinct from barbiturates. J Pharmacol Exp Ther 248:960-966[Abstract/Free Full Text].
• Twyman RE, Macdonald RL (1992) Neurosteroid regulation of GABA_A receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J Physiol (Lond) 456:215-245[Abstract/Free Full Text].
• Twyman RE, Rogers CJ, Macdonald RL (1989) Pentobarbital and picrotoxin have reciprocal actions on single GABA_A receptor channels. Neurosci Lett 96:89-95[Web of Science][Medline].
• Whiting PJ, McKernan RM, Wafford KA (1995) Structure and pharmacology of vertebrate GABA_A receptor subtypes. Int Rev Neurobiol 38:95-138[Web of Science][Medline].
• Yoo A, Harris J, Dubrovsky B (1996) Dose-response study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp Neurol 137:151-156[Web of Science][Medline].
• Zheng T, Santi MR, Bovolin P, Marlier LNJ-L, Grayson DR (1993) Developmental expression of the 6 GABA_A receptor occurs only after cerebellar granule cell migration. Dev Brain Res 75:91-103[Medline].
• Zheng T, Zhu WJ, Puia G, Vicini S, Grayson DR, Costa E, Caruncho HJ (1995) Changes in -aminobutyrate type A receptor subunits mRNAs, translation product expression, and receptor function during neuronal maturation in vitro. Proc Natl Acad Sci USA 91:10952-10956[Abstract/Free Full Text].
• Zhu WJ, Vicini S (1997) Neurosteroid prolongs GABA_A channel deactivation by altering kinetics of desensitized states. J Neurosci 17:4022-4031[Abstract/Free Full Text].
• Zhu WJ, Wang JF, Krueger KE, Vicini S (1996) subunit inhibits neurosteroid modulation of GABA_A receptors. J Neurosci 16:6648-6656[Abstract/Free Full Text].
• Zorumski CF, Mennerick S, Covey DF (1998) Enantioselective modulation of GABAergic synaptic transmission by steroids and benz[e]indenes in hippocampal microcultures. Synapse 29:162-171[Web of Science][Medline].

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/2251541-09$05.00/0

This article has been cited by other articles:

				D. Belelli, N. L. Harrison, J. Maguire, R. L. Macdonald, M. C. Walker, and D. W. Cope Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function J. Neurosci., October 14, 2009; 29(41): 12757 - 12763. [Abstract] [Full Text] [PDF]

				H.-J. Shu, L. N. Eisenman, C. Wang, A. K. Bandyopadhyaya, K. Krishnan, A. Taylor, A. M. Benz, B. Manion, A. S. Evers, D. F. Covey, et al. Photodynamic Effects of Steroid-Conjugated Fluorophores on GABAA Receptors Mol. Pharmacol., October 1, 2009; 76(4): 754 - 765. [Abstract] [Full Text] [PDF]

				R.-Z. Zhan and J. V. Nadler Enhanced Tonic GABA Current in Normotopic and Hilar Ectopic Dentate Granule Cells After Pilocarpine-Induced Status Epilepticus J Neurophysiol, August 1, 2009; 102(2): 670 - 681. [Abstract] [Full Text] [PDF]

				J. Liang, I. Spigelman, and R. W. Olsen Tolerance to Sedative/Hypnotic Actions of GABAergic Drugs Correlates With Tolerance to Potentiation of Extrasynaptic Tonic Currents of Alcohol-Dependent Rats J Neurophysiol, July 1, 2009; 102(1): 224 - 233. [Abstract] [Full Text] [PDF]

				K. H. Kaur, R. Baur, and E. Sigel Unanticipated Structural and Functional Properties of {delta}-Subunit-containing GABAA Receptors J. Biol. Chem., March 20, 2009; 284(12): 7889 - 7896. [Abstract] [Full Text] [PDF]

				E. Sanna, M. C. Mostallino, L. Murru, M. Carta, G. Talani, S. Zucca, M. L. Mura, E. Maciocco, and G. Biggio Changes in Expression and Function of Extrasynaptic GABAA Receptors in the Rat Hippocampus during Pregnancy and after Delivery J. Neurosci., February 11, 2009; 29(6): 1755 - 1765. [Abstract] [Full Text] [PDF]

				H. Matsuoka, K. Harada, Y. Endo, A. Warashina, Y. Doi, J. Nakamura, and M. Inoue Molecular mechanisms supporting a paracrine role of GABA in rat adrenal medullary cells J. Physiol., October 15, 2008; 586(20): 4825 - 4842. [Abstract] [Full Text] [PDF]

				R. W. Olsen and W. Sieghart International Union of Pharmacology. LXX. Subtypes of {gamma}-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update Pharmacol. Rev., September 1, 2008; 60(3): 243 - 260. [Abstract] [Full Text] [PDF]

				K. Vagnerova, I. P. Koerner, and P. D. Hurn Gender and the Injured Brain Anesth. Analg., July 1, 2008; 107(1): 201 - 214. [Abstract] [Full Text] [PDF]

				H. P. Goodkin, S. Joshi, Z. Mtchedlishvili, J. Brar, and J. Kapur Subunit-Specific Trafficking of GABAA Receptors during Status Epilepticus J. Neurosci., March 5, 2008; 28(10): 2527 - 2538. [Abstract] [Full Text] [PDF]

				D. R. Peden, C. M. Petitjean, M. B. Herd, M. S. Durakoglugil, T. W. Rosahl, K. Wafford, G. E. Homanics, D. Belelli, J.-M. Fritschy, and J. J. Lambert Developmental maturation of synaptic and extrasynaptic GABAA receptors in mouse thalamic ventrobasal neurones J. Physiol., February 15, 2008; 586(4): 965 - 987. [Abstract] [Full Text] [PDF]

				C. Sun, Z. Mtchedlishvili, A. Erisir, and J. Kapur Diminished Neurosteroid Sensitivity of Synaptic Inhibition and Altered Location of the {alpha}4 Subunit of GABAA Receptors in an Animal Model of Epilepsy J. Neurosci., November 14, 2007; 27(46): 12641 - 12650. [Abstract] [Full Text] [PDF]

				P. Li, H.-J. Shu, C. Wang, S. Mennerick, C. F. Zorumski, D. F. Covey, J. H. Steinbach, and G. Akk Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation J. Physiol., November 1, 2007; 584(3): 789 - 800. [Abstract] [Full Text] [PDF]

				E. E. Benarroch GABAA receptor heterogeneity, function, and implications for epilepsy Neurology, February 20, 2007; 68(8): 612 - 614. [Full Text] [PDF]

				A. Mizokami, T. Kanematsu, H. Ishibashi, T. Yamaguchi, I. Tanida, K. Takenaka, K. I. Nakayama, K. Fukami, T. Takenawa, E. Kominami, et al. Phosholipase C-Related Inactive Protein Is Involved in Trafficking of {gamma}2 Subunit-Containing GABAA Receptors to the Cell Surface J. Neurosci., February 14, 2007; 27(7): 1692 - 1701. [Abstract] [Full Text] [PDF]

				G.-D. Li, D. C. Chiara, G. W. Sawyer, S. S. Husain, R. W. Olsen, and J. B. Cohen Identification of a GABAA Receptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate Analog. J. Neurosci., November 8, 2006; 26(45): 11599 - 11605. [Abstract] [Full Text] [PDF]

				D. Chandra, F. Jia, J. Liang, Z. Peng, A. Suryanarayanan, D. F. Werner, I. Spigelman, C. R. Houser, R. W. Olsen, N. L. Harrison, et al. GABAA receptor {alpha}4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol PNAS, October 10, 2006; 103(41): 15230 - 15235. [Abstract] [Full Text] [PDF]

				J. H. Krystal, J. Staley, G. Mason, I. L. Petrakis, J. Kaufman, R. A. Harris, J. Gelernter, and J. Lappalainen {gamma}-Aminobutyric Acid Type A Receptors and Alcoholism: Intoxication, Dependence, Vulnerability, and Treatment. Arch Gen Psychiatry, September 1, 2006; 63(9): 957 - 968. [Abstract] [Full Text] [PDF]

				R. M. Kaminski, H. Marini, P. I. Ortinski, S. Vicini, and M. A. Rogawski The Pheromone Androstenol (5{alpha}-Androst-16-en-3{alpha}-ol) Is a Neurosteroid Positive Modulator of GABAA Receptors J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 694 - 703. [Abstract] [Full Text] [PDF]

				H.-J. Feng, J.-Q. Kang, L. Song, L. Dibbens, J. Mulley, and R. L. Macdonald {delta} Subunit Susceptibility Variants E177A and R220H Associated with Complex Epilepsy Alter Channel Gating and Surface Expression of {alpha}4beta2{delta} GABAA Receptors J. Neurosci., February 1, 2006; 26(5): 1499 - 1506. [Abstract] [Full Text] [PDF]

				Z. Mtchedlishvili and J. Kapur High-Affinity, Slowly Desensitizing GABAA Receptors Mediate Tonic Inhibition in Hippocampal Dentate Granule Cells Mol. Pharmacol., February 1, 2006; 69(2): 564 - 575. [Abstract] [Full Text] [PDF]

				D. A. Wagner, M. P. Goldschen-Ohm, T. G. Hales, and M. V. Jones Kinetics and Spontaneous Open Probability Conferred by the {epsilon} Subunit of the GABAA Receptor J. Neurosci., November 9, 2005; 25(45): 10462 - 10468. [Abstract] [Full Text] [PDF]

				P. S. Mangan, C. Sun, M. Carpenter, H. P. Goodkin, W. Sieghart, and J. Kapur Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors Mol. Pharmacol., March 1, 2005; 67(3): 775 - 788. [Abstract] [Full Text] [PDF]

				I. Mody Aspects of the homeostaic plasticity of GABAA receptor-mediated inhibition J. Physiol., January 1, 2005; 562(1): 37 - 46. [Abstract] [Full Text] [PDF]

				H.-J. Feng and R. L. Macdonald Multiple Actions of Propofol on {alpha}{beta}{gamma} and {alpha}{beta}{delta} GABAA Receptors Mol. Pharmacol., December 1, 2004; 66(6): 1517 - 1524. [Abstract] [Full Text] [PDF]

				H.-J. Feng, M. T. Bianchi, and R. L. Macdonald Pentobarbital Differentially Modulates {alpha}1{beta}3{delta} and {alpha}1{beta}3{gamma}2L GABAA Receptor Currents Mol. Pharmacol., October 1, 2004; 66(4): 988 - 1003. [Abstract] [Full Text] [PDF]

				Z. Peng, C. S. Huang, B. M. Stell, I. Mody, and C. R. Houser Altered Expression of the {delta} Subunit of the GABAA Receptor in a Mouse Model of Temporal Lobe Epilepsy J. Neurosci., September 29, 2004; 24(39): 8629 - 8639. [Abstract] [Full Text] [PDF]

				H.-J. Feng and R. L. Macdonald Proton Modulation of {alpha}1{beta}3{delta} GABAA Receptor Channel Gating and Desensitization J Neurophysiol, September 1, 2004; 92(3): 1577 - 1585. [Abstract] [Full Text] [PDF]

				H.-J. Shu, L. N. Eisenman, D. Jinadasa, D. F. Covey, C. F. Zorumski, and S. Mennerick Slow Actions of Neuroactive Steroids at GABAA Receptors J. Neurosci., July 28, 2004; 24(30): 6667 - 6675. [Abstract] [Full Text] [PDF]

				M. Wallner, H. J. Hanchar, and R. W. Olsen From The Cover: Ethanol enhances {alpha}4{beta}3{delta} and {alpha}6{beta}3{delta} {gamma}-aminobutyric acid type A receptors at low concentrations known to affect humans PNAS, December 9, 2003; 100(25): 15218 - 15223. [Abstract] [Full Text] [PDF]

				M. T. Bianchi and R. L. Macdonald Neurosteroids Shift Partial Agonist Activation of GABAA Receptor Channels from Low- to High-Efficacy Gating Patterns J. Neurosci., November 26, 2003; 23(34): 10934 - 10943. [Abstract] [Full Text] [PDF]

				B. M. Stell, S. G. Brickley, C. Y. Tang, M. Farrant, and I. Mody Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by {delta} subunit-containing GABAA receptors PNAS, November 25, 2003; 100(24): 14439 - 14444. [Abstract] [Full Text] [PDF]

				W. Wei, N. Zhang, Z. Peng, C. R. Houser, and I. Mody Perisynaptic Localization of {delta} Subunit-Containing GABAA Receptors and Their Activation by GABA Spillover in the Mouse Dentate Gyrus J. Neurosci., November 19, 2003; 23(33): 10650 - 10661. [Abstract] [Full Text] [PDF]

				D. Belelli and M. B. Herd The Contraceptive Agent Provera Enhances GABAA Receptor-Mediated Inhibitory Neurotransmission in the Rat Hippocampus: Evidence for Endogenous Neurosteroids? J. Neurosci., November 5, 2003; 23(31): 10013 - 10020. [Abstract] [Full Text] [PDF]

				S. D. Sullivan and S. M. Moenter Neurosteroids Alter {gamma}-Aminobutyric Acid Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons: A Possible Mechanism for Direct Steroidal Control Endocrinology, October 1, 2003; 144(10): 4366 - 4375. [Abstract] [Full Text] [PDF]

				I. Spigelman, Z. Li, J. Liang, E. Cagetti, S. Samzadeh, R. M. Mihalek, G. E. Homanics, and R. W. Olsen Reduced Inhibition and Sensitivity to Neurosteroids in Hippocampus of Mice Lacking the GABAA Receptor {delta} Subunit J Neurophysiol, August 1, 2003; 90(2): 903 - 910. [Abstract] [Full Text] [PDF]

				K. Bollan, D. King, L. A. Robertson, K. Brown, P. M. Taylor, S. J. Moss, and C. N. Connolly GABAA Receptor Composition Is Determined by Distinct Assembly Signals within alpha and beta Subunits J. Biol. Chem., February 7, 2003; 278(7): 4747 - 4755. [Abstract] [Full Text] [PDF]

				E. Cagetti, J. Liang, I. Spigelman, and R. W. Olsen Withdrawal from Chronic Intermittent Ethanol Treatment Changes Subunit Composition, Reduces Synaptic Function, and Decreases Behavioral Responses to Positive Allosteric Modulators of GABAA Receptors Mol. Pharmacol., January 1, 2003; 63(1): 53 - 64. [Abstract] [Full Text] [PDF]

				R.-Q. Huang and G. H. Dillon Functional Characterization of GABAA Receptors in Neonatal Hypothalamic Brain Slice J Neurophysiol, October 1, 2002; 88(4): 1655 - 1663. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (130) Citing Articles via Google Scholar Google Scholar Articles by Wohlfarth, K. M. Articles by Macdonald, R. L. Search for Related Content PubMed PubMed Citation Articles by Wohlfarth, K. M. Articles by Macdonald, R. L.

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help